Answers are grounded in this paper and cite their sources.
Three-dimensional culture systems have emerged as a bridge between in vitro and in vivo models. Organoids and spheroids derived from human stem cells can model cellular interactions, morphology and organization of the neocortex, and provide a platform for future translational research into neurological disorders. However, the heterogeneity commonly found in 3D culture systems presents considerable challenges for identifying significant, reproducible, and disorder-relevant phenotypes. Here, we present a rigorous methodological framework for the longitudinal analysis of dorsal forebrain spheroids, beginning with gross spheroid morphology, extending to structural phenotypes in rosette morphogenesis, and culminating in cellular analyses of neural progenitor cell proliferation and cell cycle dynamics. This workflow integrates isogenic iPSC-derived spheroid culture, whole-mount optical clearing, high-resolution 3D imaging and reconstruction, and cumulative EdU-labeling assays. Testing the sensitivity of this approach in an isogenic Down syndrome model, we reliably detected new features of altered spheroid growth, delayed rosette emergence, reduced rosette density, and prolonged progenitor cell cycle progression. This approach provides a reproducible strategy for measuring complex developmental phenotypes in 3D culture models and can be applied to neurodevelopmentally altered cell lines beyond Down syndrome.
No takes yet. Share an insight, caveat, or question.
Ayoub et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: